59 related articles for article (PubMed ID: 33393677)
1. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
[TBL] [Abstract][Full Text] [Related]
2. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
[TBL] [Abstract][Full Text] [Related]
3. Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study.
Liew JW; Peloquin C; Tedeschi SK; Felson DT; Zhang Y; Choi HK; Terkeltaub R; Neogi T
Arthritis Care Res (Hoboken); 2022 Dec; 74(12):2059-2065. PubMed ID: 35245410
[TBL] [Abstract][Full Text] [Related]
4. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children.
Noh Y; Jeong HE; Choi A; Choi EY; Pasternak B; Nordeng H; Bliddal M; Man KKC; Wong ICK; Yon DK; Shin JY
JAMA Pediatr; 2023 Mar; 177(3):267-277. PubMed ID: 36622684
[TBL] [Abstract][Full Text] [Related]
5. Effect of Gastric Acid Suppressants on Response to a Physical Activity Intervention and Major Mobility Disability in Older Adults: Results from the Lifestyle Interventions for Elders (LIFE) Study.
Squires PJ; Pahor M; Manini TM; Brown JD
Pharmacotherapy; 2019 Aug; 39(8):816-826. PubMed ID: 31230397
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
[TBL] [Abstract][Full Text] [Related]
7. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
[TBL] [Abstract][Full Text] [Related]
9. Association between proton pump inhibitors use and risk of asthma in Korea: A prevalent new-user cohort study.
Lim HJ; Oh IS; Noh Y; Yon DK; Shin JY
Medicine (Baltimore); 2024 Jan; 103(1):e36772. PubMed ID: 38181266
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
[TBL] [Abstract][Full Text] [Related]
11. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
12. Association Between Acid-Suppressive Drugs and Risk of Rosacea: Retrospective Study Using the Korean National Health Insurance Service-National Sample Cohort.
Kim JH; Min JH; Jo YW; Kwon JW; Her Y
J Korean Med Sci; 2023 Dec; 38(47):e402. PubMed ID: 38050914
[TBL] [Abstract][Full Text] [Related]
13. Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.
Vilmar A; Dehlendorff C; Friis S; Jäättelä M; Tvingsholm S; Frederiksen H
Leuk Lymphoma; 2023; 64(8):1451-1457. PubMed ID: 37293759
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.
Maret-Ouda J; Panula J; Santoni G; Xie S; Lagergren J
J Gastroenterol; 2023 Aug; 58(8):734-740. PubMed ID: 37314495
[TBL] [Abstract][Full Text] [Related]
15. Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study.
Murofushi T; Yagi T; Tsuji D; Furushima D; Fujikura T; Itoh K; Kawakami J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; ():. PubMed ID: 38170305
[TBL] [Abstract][Full Text] [Related]
16. Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.
Huang CH; Tseng YH; Tsai WS; Su CC; Cheng CL; Kao Yang YH; Chang YC; Liu YH
Infect Dis Ther; 2024 Feb; 13(2):373-383. PubMed ID: 38286955
[TBL] [Abstract][Full Text] [Related]
17. Comment on "Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study".
Lai SW; Hwang BF; Liu CS; Liao KF
Eur J Clin Pharmacol; 2024 Apr; 80(4):621-622. PubMed ID: 38294552
[No Abstract] [Full Text] [Related]
18. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer.
Wu CC; Fang CY; Yu BH; Chang CM; Hsu TW; Hung CL; Hung SK; Chiou WY; Tsai JH
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958477
[TBL] [Abstract][Full Text] [Related]
19. The Mortality Risk of Proton Pump Inhibitors in 1.9 Million US Seniors: An Extended Cox Survival Analysis.
Baik SH; Fung KW; McDonald CJ
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e671-e681. PubMed ID: 33453399
[TBL] [Abstract][Full Text] [Related]
20. Predicting mortality from acetaminophen poisoning shortly after hospital presentation.
Yarema MC; Johnson DW; Sivilotti MLA; Nettel-Aguirre A; DeWitt C; Gosselin S; Murphy N; Victorino C; Bailey B; Dong K; Haney E; Purssell R; Thompson M; Lord JA; Spyker DA; Rumack BH
Br J Clin Pharmacol; 2021 Aug; 87(8):3332-3343. PubMed ID: 33507553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]